We recently developed two rat pituitary GH3 cell clones engineered to secrete human insulin (InsGH3). InsGH3 cells convert proinsulin into mature insulin, which is partially stored into a readily releasable pool of secretory granules. The efficiency of these processes, however, is relatively low in these cells, either in vitro or in vivo. This study was aimed at determining whether carboxypeptidase E (Cpe) overexpression can increase proinsulin processing and regulated secretion by InsGH3 clones. Indeed, in its membrane-bound form Cpe works as sorting receptor for the regulated secretory pathway of many hormones while, in its soluble form, Cpe takes part to the late step of insulin maturation. We obtained two Cpe-overexpressing cell lines from two different InsGH3 clones (InsGH3/C1 and C7). In the Cpe-overexpressing cell lines, derived from InsGH3 of clone 1 (InsGH3/C1-HACpe), in which the membrane-bound form of exogenous Cpe is accounted for by 90% of total Cpe immunoreactivity, we observed an increase in proinsulin gene expression, and in basal and stimulated insulin secretion compared with the original clone. In contrast, in the Cpeoverexpressing cell line derived from InsGH3 of clone 7 (InsGH3/C7-HACpe), where the exogenous membrane-bound form was only 60% of total Cpe, we detected a decrease in basal insulin release and a modest, albeit significant, increase in intracellular proinsulin processing. In conclusion, Cpe overexpression can increase regulated insulin secretion and proinsulin processing in InsGH3 cells; however, such improvements appear quantitatively and qualitatively modest. 
INTRODUCTION
agents and can survive in vitro at extremely high density. This peculiar resistance to cell death signals has We recently proposed bioengineered insulin-secreting been related to their naturally high levels of antiapoppituitary cells as potential β-cell surrogates for encapsutotic Bcl-2 protein (12, 16) . Although proinsulin is prolation-based diabetes cell therapy (5, 16) . Pituitary cells cessed to mature insulin by InsGH3 cells, this process is are interesting because they have a regulated secretory not particularly efficient and mature insulin accounts for pathway (RSP) of protein secretion (21) and, in contrast only 40% of total released proinsulin forms. Targeting to pancreatic β-cells (22,24), are not recognized by cytoof proinsulin transgene products to the RSP was contoxic antibodies present in sera of diabetic NOD mice firmed by immunofluorescence that showed the colocal-(20). Moreover, insulin-secreting pituitary cells transization of insulin with secretogranin II (a marker of regplanted into spontaneously diabetic NOD mice escape ulated secretion), and by the ability of InsGH3 cells to the recurrence of autoimmune destruction and survive increase insulin release in response to an acute stimulaindefinitely after implantation (14) .
tion. Moreover, implantation of InsGH3 cells into strepWe previously developed two insulin-secreting GH3 tozotocin-induced diabetic mice reversed hyperglycemia cell clones (InsGH3/C1 and InsGH3/C7) stably transfecand induced the appearance of circulating human c-pepted with a modified furin-cleavable human proinsulin tide, proinsulin, and insulin levels of about 9, 32, and 35 cDNA (7) placed under the control of the prolactin propmol/L, respectively. However, uncontrolled graft growth moter (5, 16 Encapsulation, which represents a physical barrier against and, 24 h later, the cells were transfected with the plasmid by using Lipofectin (GIBCO/BRL) following the uncontrolled cell growth, may control tumorigenicity but the only way to increase proinsulin processing and semanufacturer's instructions. After 3 weeks of culture, cells resistant to 0.25 mg/ml of hygromycin (GIBCO/ cretagogue-induced (regulated) secretion is to perform further engineering of InsGH3 cells. BRL) were trypsinized, collected, and expanded as cell lines (InsGH3/C1-HACpe and InsGH3/C7-HACpe). All Insulin is synthesized into the rough endoplasmic reticulum as a larger precursor (preproinsulin); preproinexperiments were performed between passages 2 and 15. sulin is then transported to the trans-Golgi, where it segNorthern Blot Analysis regates into the vesicles of the RSP and where the endo-
The expression of human proinsulin, Cpe, and riboproteases PC1 and PC3 transform proinsulin into mature somal 18S genes was analyzed in InsGH3 and InsGH3/ insulin. Finally, secretory granules rich of mature insulin HACpe cells. Total cellular RNA was prepared with the (>90%) are released by a Ca 2+ -dependent exocytotic pro-RNAFAST isolation system (Biotecx Laboratories Inc., cess (1, 15, 23) . Protein aggregation and the presence of Houston, TX) and Northern blot analysis was pera sorting receptor are the two models proposed to exformed. Twenty micrograms of total RNA from each plain how proteins are selectively targeted to the RSP sample was denaturated with formaldehyde, electropho-(1,15). The latter hypothesis is supported by the identifiresed on 1% denaturing agarose gel, and blotted to a cation of a specific sorting signal motif in many prohorHybond nylon membrane. Blots were hybridized with mones (2, 3) , and by the demonstration that the mem-32 P-labeled human modified insulin, ribosomal 18S, and brane-bound form of carboxypeptidase E (Cpe) acts as HindIII/XhoII fragment of rat Cpe cDNA (1.2 kb) probes. a sorting receptor (4). Moreover, in its soluble form, Cpe
Relative expression levels of proinsulin, Cpe, and riboparticipates to the last step of insulin processing by resomal 18S mRNA were determined by densitometric moving basic residues from the C-terminal region of the analysis. proinsulin molecule (15 Secretagogue-induced mature insulin release by Ins-100 IU/ml streptomycin/penicillin (DMEM-c). Cultures GH3 and InsGH3/HACpe cells was studied by static inwere performed under standard humidified culture concubation. Cells were plated (1.6 × 10 5 cells per well) into ditions of 5% CO 2 and 95% air at 37°C.
24-well plates and cultured overnight in standard tissue Expression Vector and Transfection culture medium. The following day, cells were washed in phosphate-buffered saline (PBS) and then incubated The rat carboxypeptidase E cDNA, fused in the N-terminal region to the HA epitope tag of the human for 60 min in plain medium (without FCS), with the addition of 10 µmol/L forskolin (FSK). After incubainfluenza virus (HACpe), was kindly provided by Dr. Lloyd Friker (Albert Einstein College of Medicine, tion, supernatants were collected and stored at −20°C until assayed for mature insulin as described. Cell lyBronx, NY). HACpe was cloned into pCEP4 expression vector, containing the hygromycin resistance gene, unsates were prepared for the measurement of total protein and insulin content, and insulin release was expressed in der the control of the CMV promoter. About 5 × 10
Immunocytochemistry
InsGH3 and Cpe-overexpressing cells were fixed in 4% paraformaldehyde in PBS for 10 min. Cells were blocked for 20 min in 20% normal goat serum in PBS (PBS/NGS), then permeabilized for 10 min with 0.15% Triton X-100 in PBS/NGS and incubated into antiinsulin (mouse anti-human 1:100, Signet Laboratoires Inc., Dedham, MA) at 37°C for 1.5 h. After three washes with PBS, cells were incubated with secondary antibody (1:2000) at room temperature for 1 h, washed three times with PBS, and nuclei were marked with DAPI (Sigma, St. Louis, MO, dil. 1:50 from 1 µg/ml in ethanol) for 10 min. All experiments were analyzed with a fluorescence microscope.
Statistical Analysis
Experiments were repeated at least three times. Data were expressed as means ± SE. Statistical analysis was performed using the unpaired Student's t-test. Statistical significance was considered at p < 0.05.
RESULTS

Development of InsGH3/HACpe Lines and HACpe Distribution
After transfection and selection, hygromicin-resistent cells of clone 1 and clone 7 were pooled to develop the InsGH3/C1-HACpe and InsGH3/C7-HACpe lines. As shown in Figure 1 , Cpe overexpression in these lines was confirmed at different passages by Northern Blot analysis. Compared with clones 1 and 7, which showed a similar level of endogenous Cpe (Fig. 1) , InsGH3/ C1-HACpe and InsGH3/C7-HACpe showed a significant increase in Cpe mRNA levels of about three-and full-length membrane-bound (upper band) and truncated soluble (lower band) forms of Cpe. To assess the relative distribution of exogenous Cpe in its two form, the pared with untrasfected clone 7. Conversely, no differpercentage of membrane-bound versus soluble form was ences were found after Cpe overexpression in clone 1. analyzed at the densitometer (Fig. 2, lower panel) . In
InsGH3/C1-HACpe and InsGH3/C7-HACpe revealed InsGH3/C1-HACpe, more than 90% of HACpe immua diverse response in basal insulin release after Cpe noreactivity was localized in the membrane-bound form, overexpression. Indeed, release of mature insulin was while in Ins GH3/C7-HACpe cells exogenous Cpe was markedly increased in clone 1 (about 195% of untransfelocalized to about 60% in the membrane-bound form cted cells), while it decreased (57% of untransfected and 40% in the soluble form. cells) in clone 7 (Table 1) .
Basal Insulin Content and Release in (Pro)Insulin Processing Cpe-Overexpressing Lines
As shown in Table 1 , InsGH3/C7-HACpe showed a The percentage of mature insulin in media and extract of InsGH3/HACpe lines was measured and compared significant decrease in mature insulin content when com- with those of original clones (Table 2) . A significant when compared with untransfected InsGH3/C1). Conversely, FSK-stimulated insulin release did not change increase in mature insulin was detected in InsGH3/ C7-HACpe extract (from 51% to 66%). In contrast, no in InsGH3/C7-HACpe. differences were observed in the percentage of mature Immunocytochemistry Analysis insulin secretion by Cpe-overexpressing InsGH3 cells InsGH3/C1 cells transfected with Cpe showed a cytowhen compared with untransfected controls.
plasmic pattern of insulin immunoreactivity slightly Forskolin-Induced Insulin Release different from control cells (Fig. 4) . Indeed, insulin immunoreactivity in InsGH3/C1-HACpe appeared more In InsGH3 cells of both clones, FSK induced a dosedependent increase in insulin secretion that was maximal granular and mainly localized under the plasma membrane than in InsGH3/C1 cells. No difference was noted at 10 µmol/L (16). As shown in Figure 3 , after Cpe overexpression the insulin response to FSK increased between InsGH3/C7 and InsGH3/C7-HACpe cells (data not shown). further in InsGH3/C1-HACpe (about 50% increase Human Proinsulin mRNA Levels matic activity and binds prohormomes such as proinsulin, proenkephalin, and POMC in a first-order kinetics Cpe overexpression did not induced any significant similar to that of enzyme-substrate interaction (4). The modification in proinsulin mRNA levels of Cpe-overexprohormone binding domain is distinct from the catapressing cells derived from clone 7. In contrast, proinsulytic domain and becomes accessible only when Cpe is lin mRNA levels were significantly higher in InsGH3/ bound to the membranes of the trans-Golgi network or C1-HACpe cells than in their untransfected control cells the secretory vesicles (26) . Moreover, the binding of (Fig. 5) .
Cpe with the cholesterol-glycolipid raft is necessary for DISCUSSION its sorting receptor function (6). Previous reports have clearly shown the fundamental In β-cells and neuroendocrine cells, Cpe is present in a membrane-bound form, localized on the trans-Golgi role of Cpe in the processing of the prehormones in their and secretory vesicle membranes, and in a soluble form.
active forms. Neuro-2a cells, in which Cpe expression The latter derives from the proteolytic cleavage of the was completely abolished by antisense technology (Neuro-C-terminal region, which is essential for the binding of 2a Cpe −/− cells), secrete completely unprocessed proenCpe to the membranes (15, 17) . The soluble form of Cpe kephalin via the constitutive pathway (4,19). Lack of is an enzymatically active endoprotease (11, 15, 23) , Cpe activity was studied also in Cpe fat mice, which have while the membrane-bound form does not have enzya single point mutation in the Cpe gene that leads to the transcription of an enzymatically inactive protein. The phenotype of these mice is characterized by obesity, in- and that β-cell lines derived from Cpe fat mice secrete InsGH3/C1-HACpe 47 ± 6 3 0 ± 9 unprocessed proinsulin but in a regulated manner (25), InsGH3/C7 51 ± 5 2 6 ± 6 suggest that Cpe may be not strictly necessary for horInsGH3/C7-HACpe 66 ± 9* 33 ± 10 mone sorting to the RSP. Cpe mRNA levels were about three-and sixfold higher ( Fig. 1) . As previously described to occur for the proinlevels, which were similar in InsGH3/C7 cells before and after Cpe overexpression. Therefore, reduced insulin sulin gene (16), exogenous Cpe gene was transcribed more efficiently in InsGH3/C7 than in InsGH3/C1. biosynthesis must have occurred at the posttranscriptional level, probably as a result of the increased carThe effect of Cpe overexpression in InsGH3 cells varied depending on the relative distribution of its soluboxypeptidase activity present in the cell. Indeed, the extremely high levels of enzymatically active form of ble and membrane-bound form of protein. In InsGH3/ C7-HACpe cells, 60% of total Cpe immunoreactivity Cpe present in these cells could react with other molecules and interfere with the normal proinsulin biosynwas detected in its membrane-bound form and only 40% in its soluble form (Fig. 2) . This situation resembles the thesis.
In the other Cpe-overexpressing cell line (InsGH3/ endogenous distribution of Cpe in AtT20 cells (9) , and suggests that the membrane-bound/soluble Cpe ratio re-C1-HACpe), exogenous Cpe was prevalently expressed in its membrane-bound form (90% of total HACpe immained unaffected in InsGH3/C7-HACpe cells. Perhaps this is the reason why sixfold higher Cpe mRNA levels munoreactivity) (Fig. 2) . Proinsulin processing was unchanged in InsGH3/C1-HACpe (Table 2) , which showed did not induce any changes in regulated insulin secretion by these cells. Instead, InsGH3/C7-HACpe cells showed a significant increase in basal (Table 1 ) and in regulated (FSK-induced) mature insulin release (Fig. 3) . The high a significant increase in intracellular proinsulin processing (Table 2 ) compared with the original. Indeed, it basal release of insulin by InsGH3/C1-HACpe cell line might be partially explained by the higher level of exshould be noted that all the other forms of unprocessed proinsulin decreased more dramatically in InsGH3/C7-pression of the proinsulin gene, observed in these cells, compared with their untransfected controls (Fig. 5) . As HACpe, because the ratio between mature insulin over total immunoreactive insulin increased significantly in already stated, FSK-induced (regulated) insulin release also increased significantly in InsGH3/C1-HACpe ( (Table 2) . Nevertheless, the increase in percentage of mature insulin in extract of InsGH3/C7-3). Perhaps in these cells, Cpe overexpression, by increasing its membrane-bound form, has more efficiently HACpe indicates that a modest increase in proinsulin processing must have occurred in these cells. It should targeted insulin into the RSP and in the secretory granules. The evidence that in InsGH3/C1-HACpe cells inbe noted, however, that the efficiency of proinsulin processing was significantly higher in wild-type GH3 cells sulin immunoreactivity appears more granular compared with their original clone (Fig. 4) supports this hypothecotransfected with proinsulin and the β-cell-specific endoproteases PC1 and PC3 (13) . sis. However, ultrastructural studies showed that the pool of secretory granules was not quantitatively increased The decrease in total immunoreactive insulin forms cannot be explained by a decrease in proinsulin mRNA in InsGH3/C1-HACpe (data not shown). Immunoelec- tromicroscopy with antibodies against insulin (or proini) insulin mRNA levels, ii) basal and regulated insulin secretion, and iii) proinsulin processing. The effects of sulin) was not performed in this study. Therefore, we cannot exclude that an increase in mature insulin content Cpe overexpression were related to the subcellular localization of the exogenous Cpe protein. The increase in would have occurred in the granules of these cells. It is also possible that exogenous membrane-bound Cpe, by the membrane-bound form augmented regulated secretion, while the increase in the soluble form improved facilitating the translocation of insulin from the transGolgi to the granules (accordingly to the receptor-mediproinsulin processing to mature insulin. However, albeit statistically significant, these effects were of small magated sorting model), might accelerate the process of granule formation and fusion to the plasma membrane, nitude, probably because endogenous Cpe is already abundantly expressed in neuroendocrine cells. Other thereby decreasing the half-life of the granules in the cells.
strategies might therefore be explored to render the insulin secretory machinery of pituitary GH3 cells more simIn conclusion, Cpe overexpression into insulin-secreting pituitary GH3 cells (InsGH3) caused an increase in: ilar to that of the pancreatic β-cell. In contrast, no differences were detected between InsGH3/C7 and InsGH3/ C7-HACpe cells.
